Published in Kidney Int on March 01, 1996
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol (2001) 4.39
Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol (2010) 3.25
Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol (2010) 2.55
Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest (2010) 2.23
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int (2011) 2.15
Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats. Naunyn Schmiedebergs Arch Pharmacol (2014) 1.45
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol (1999) 1.42
Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology (2001) 1.36
Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest (1998) 1.26
JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest (2003) 1.22
Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol (1999) 1.19
Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions. Am J Pathol (2001) 1.16
The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol (2008) 1.15
Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One (2010) 1.15
Role of atrophic tubules in development of interstitial fibrosis in microembolism-induced renal failure in rat. Am J Pathol (2001) 1.04
Increased cellular senescence and vascular rarefaction exacerbate the progression of kidney fibrosis in aged mice following transient ischemic injury. PLoS One (2013) 0.99
Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease. J Am Soc Nephrol (2011) 0.98
Immune and inflammatory role in renal disease. Compr Physiol (2013) 0.97
HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair (2013) 0.96
Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury. Am J Pathol (1999) 0.90
Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy. Clinics (Sao Paulo) (2012) 0.84
Exercise attenuates renal dysfunction with preservation of myocardial function in chronic kidney disease. PLoS One (2013) 0.82
Postnatal renal development of rats from mothers that received increased sodium intake. Pediatr Nephrol (2004) 0.82
Combined C4d and CD3 immunostaining predicts immunoglobulin (Ig)A nephropathy progression. Clin Exp Immunol (2015) 0.82
Mitochondrial impairment in the five-sixth nephrectomy model of chronic renal failure: proteomic approach. BMC Nephrol (2013) 0.81
Role of kidney biomarkers of chronic kidney disease: An update. Saudi J Biol Sci (2014) 0.79
Brazilian red propolis attenuates hypertension and renal damage in 5/6 renal ablation model. PLoS One (2015) 0.79
Cordyceps cicadae extracts ameliorate renal malfunction in a remnant kidney model. J Zhejiang Univ Sci B (2011) 0.79
Long-term evolution of the acute tubular necrosis (ATN) induced by glycerol: role of myofibroblasts and macrophages. Int J Exp Pathol (2002) 0.78
Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice. PLoS One (2016) 0.77
Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model. Evid Based Complement Alternat Med (2011) 0.77
Effect of 5/6 nephrectomized rat serum on epithelial-to-mesenchymal transition in vitro. Ren Fail (2011) 0.77
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat. AAPS J (2015) 0.76
Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation. Clinics (Sao Paulo) (2017) 0.75
Stop chronic kidney disease progression: Time is approaching. World J Nephrol (2016) 0.75
Blocking innate immunity to slow the progression of chronic kidney disease. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Urinary monocyte chemoattractant protein-1 levels and interstitial changes in the renal cortex and their relationship with loss of renal function in renal transplant patients with delayed graft function. Can J Kidney Health Dis (2015) 0.75
Morphofunctional renal alterations in rats induced by intrauterine hyperglycemic environment. Arch Med Sci (2015) 0.75
Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int (2016) 0.75
MAPK and angiotensin II receptor in kidney of newborn rats from losartan-treated dams. Pediatr Nephrol (2008) 0.75
A new protein containing an SH2 domain that inhibits JAK kinases. Nature (1997) 6.28
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem (1999) 5.81
Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol (1999) 4.77
Noncontact anterior cruciate ligament injuries: risk factors and prevention strategies. J Am Acad Orthop Surg (2000) 4.61
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest (2000) 4.60
Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest (1978) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Osteopontin is expressed in human aortic valvular lesions. Circulation (1995) 4.16
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J (1999) 3.77
In situ immune complex formation and glomerular injury. Kidney Int (1980) 3.52
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell (1999) 3.15
CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood (1997) 3.08
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med (2001) 3.05
MDM2 interacts with MDMX through their RING finger domains. FEBS Lett (1999) 2.98
Negative regulation of cytokine signaling pathways. Annu Rev Immunol (2000) 2.98
Rice gibberellin-insensitive dwarf mutant gene Dwarf 1 encodes the alpha-subunit of GTP-binding protein. Proc Natl Acad Sci U S A (1999) 2.97
Spred is a Sprouty-related suppressor of Ras signalling. Nature (2001) 2.87
The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol (1991) 2.77
Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect Immun (1994) 2.73
Local hyperthermia in combination with definitive radiotherapy: increased tumor clearance, reduced recurrence rate in extended follow-up. Int J Radiat Oncol Biol Phys (1984) 2.72
Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum (1997) 2.70
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol (1996) 2.60
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun (1997) 2.51
Factors effecting late results after meniscectomy. J Bone Joint Surg Am (1974) 2.49
The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol (1999) 2.44
Infectious cell entry mechanism of influenza virus. J Virol (1982) 2.41
Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes (Lond) (2009) 2.39
Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci U S A (1992) 2.29
The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J Biol Chem (2001) 2.29
Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells (1999) 2.28
Uncoating of influenza virus in endosomes. J Virol (1984) 2.26
Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem (1999) 2.21
SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell (1999) 2.19
The use of health services by older adults. J Gerontol (1991) 2.18
VEGF(165) mediates glomerular endothelial repair. J Clin Invest (1999) 2.18
Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest (2001) 2.15
Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant (1998) 2.15
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
A new role for complement in experimental membranous nephropathy in rats. J Clin Invest (1980) 2.11
Experimental membranous glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals. J Clin Invest (1980) 2.07
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Mechanical changes in the knee after meniscectomy. J Bone Joint Surg Am (1976) 2.00
Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med (2001) 2.00
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem (2000) 1.97
Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet (1976) 1.96
Strain within the anterior cruciate ligament during hamstring and quadriceps activity. Am J Sports Med (1986) 1.95
Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J Exp Med (2001) 1.95
Autopsy findings in the acquired immune deficiency syndrome. JAMA (1984) 1.91
Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest (1994) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Trends in skiing injuries. Analysis of a 6-year study (1972 to 1978). Am J Sports Med (1980) 1.86
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum (1998) 1.86
The risk of nursing home placement and subsequent death among older adults. J Gerontol (1992) 1.86
Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol (1998) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis (1999) 1.81
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int (2000) 1.79
The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood (2000) 1.78
Structure, function, and activation of the erythropoietin receptor. Blood (1993) 1.77
Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins. J Biol Chem (2001) 1.76
New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest (1987) 1.75
A "weight-listing" paradox for candidates of renal transplantation? Am J Transplant (2006) 1.75
Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int (2001) 1.75
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene (2006) 1.73
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's disease. J Clin Oncol (1988) 1.73
Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation (1995) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Differences in the synthesis and kinetics of release of interleukin 1 alpha, interleukin 1 beta and tumor necrosis factor from human mononuclear cells. Eur J Immunol (1989) 1.72
Changes in functional status and the risks of subsequent nursing home placement and death. J Gerontol (1993) 1.71
SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol (1999) 1.69
The strain behavior of the anterior cruciate ligament during squatting and active flexion-extension. A comparison of an open and a closed kinetic chain exercise. Am J Sports Med (1998) 1.68
A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood (1998) 1.68
Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int (1985) 1.67
Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol (1990) 1.67
Perceived health status and mortality among older men and women. J Gerontol (1992) 1.67
Gastrostomy insertion: comparing the options--PEG, RIG or PIG? Clin Radiol (2003) 1.67
Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. Kidney Int (2007) 1.66
Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int (1998) 1.66
Mechanisms of glomerular injury in immune-complex disease. Kidney Int (1985) 1.64
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res (1995) 1.64
Heat shock proteins and thermotolerance; a comparison of induction kinetics. Br J Radiol (1982) 1.64
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63